Medtech manufacturers and private hospitals back trade margin rationalisation but seek a fact-based approach that accounts for category-specific costs and procurement structures
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.
